Secukinumab monotherapy as efficient as adalimumab Presented ByProf. Iain McInnes, University of Glasgow, United Kingdom TrialPhase 3, EXCEED ConferenceEULAR 2020 TypePeer-reviewed article 14 August 2020 13:11